NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

electroCore, Inc. (ECOR) Stock Analysis

electroCore, Inc. (ECOR) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

ECOR

$7.35

−$0.14 (−1.87%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ECOR with… →

ECOR Key Statistics

As of Oct 21, 2026
Trading
Open
$7.95
Previous Close
$7.49
Day's Range
7.27–7.95
52-Week Range
4.41–12.70
Volume
53.14K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.05
Valuation
Market Cap
$66.27M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.79
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.65
Financials (FY)
Revenue (FY)
$32.03M+27.20%
Net Income (FY)
−$13.97M
Profit marginThe share of revenue left as profit after all costs and taxes.
−39.96%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
9.02M
1-Year Return
+47.89%
Dividend and dates
Earnings Date
November 4, 2026
Avg Volume
85.45K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ECOR closed at $7.35, +47.89% over 1 year.

electroCore, Inc. (ECOR) has a market capitalization of $66.27M.

In fiscal 2025, ECOR reported revenue of $32.03M.

ECOR Stock Return by Calendar Year

electroCore, Inc. (ECOR) return since Jun 2018: what $10,000 became

1 year
$10,000 $14,789
+47.89%
5 years
$10,000 $5,088
−49.12%
Since Jun 2018
$10,000 $247
−97.53%

If you had invested $10,000 in electroCore, Inc. (ECOR) at the close on June 22, 2018, the earliest close on record here, it would have been worth $247 at the close on October 21, 2026: −97.53% in total, −35.87% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+63.88%
2025−72.33%
2024+172.35%
2023+54.40%
2022−55.92%
2021−62.63%
2020−1.89%
2019−74.60%
2018 (partial year)−68.46%

As of October 21, 2026.

ECOR Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$32.03M−$13.97M−43.6%
2024$25.18M−$11.89M−47.2%
2023$16.03M−$18.83M−117.5%
2022$8.59M−$22.16M−257.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$32.03M$27.79M−$13.15M−$13.97M−43.6%
2024$25.18M$21.40M−$12.16M−$11.89M−47.2%
2023$16.03M$13.23M−$19.27M−$18.83M−117.5%
2022$8.59M$6.98M−$22.87M−$22.16M−257.9%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ECOR Valuation vs Medical Devices Median

Median of 145 stocks
MetricECORMedical Devices medianvs median
P/S ratio1.792.5329% below
Profit margin−39.96%−14.78%25.2 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 9 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

electroCore, Inc. (ECOR) carries a market capitalisation of $66.27M. The company sits in the Healthcare sector, in the Medical Devices industry. Headcount on file is 83.

Over the past 52 weeks the price has ranged from $4.41 to $12.70. ECOR last closed at $7.35 on October 21, 2026. That is −$0.14 (−1.87%) against the previous close. The latest close sits 66.67% above that 52-week low.

Financial Health

In fiscal 2025, electroCore, Inc. reported revenue of $32.03M. Against the prior fiscal year total of $25.18M, that is a change of +27.20%. The same year closed with a net loss of $13.97M. The reported profit margin is −39.96%. That is 25.2 percentage points below the Medical Devices median of −14.78%. Earnings per share on a trailing basis come to −1.65.

Across the 4 fiscal years on file, revenue moves from $8.59M in 2022 to $32.03M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 1.79 times revenue. On price-to-sales that is 29.14% below the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The reported beta is 1.05. Annualized volatility over the trailing 8 years is 129.23%. The trailing one-year total return is +47.89%. Measured over 5 years, that is −12.64% a year compounded.

Growth & Income

No dividend is on file for ECOR.

The strongest complete calendar year on file is 2024 at +172.35%; the weakest is 2019 at −74.60%. Of the 7 complete calendar years on file, 2 finished higher. 2026 is still running; the total return is +63.88% year to date.

Peer Comparison

electroCore, Inc. (ECOR) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
electroCore, Inc. ECOR $66.27M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. electroCore, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About electroCore, Inc.

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Visit website →